Literature DB >> 12958591

All-trans retinoic acid is a ligand for the orphan nuclear receptor ROR beta.

Catherine Stehlin-Gaon1, Dominica Willmann, Denis Zeyer, Sarah Sanglier, Alain Van Dorsselaer, Jean-Paul Renaud, Dino Moras, Roland Schüle.   

Abstract

Retinoids regulate gene expression through binding to the nuclear retinoic acid receptors (RARs) and retinoid X receptors (RXRs). In contrast, no ligands for the retinoic acid receptor-related orphan receptors beta and gamma (ROR beta and gamma) have been identified, yet structural data and structure-function analyses indicate that ROR beta is a ligand-regulated nuclear receptor. Using nondenaturing mass spectrometry and scintillation proximity assays we found that all-trans retinoic acid (ATRA) and several retinoids bind to the ROR beta ligand-binding domain (LBD). The crystal structures of the complex with ATRA and with the synthetic analog ALRT 1550 reveal the binding modes of these ligands. ATRA and related retinoids inhibit ROR beta but not ROR alpha transcriptional activity suggesting that high-affinity, subtype-specific ligands could be designed for the identification of ROR beta target genes. Our results identify ROR beta as a retinoid-regulated nuclear receptor, providing a novel pathway for retinoid action.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12958591     DOI: 10.1038/nsb979

Source DB:  PubMed          Journal:  Nat Struct Biol        ISSN: 1072-8368


  81 in total

Review 1.  Orphan nuclear receptors as targets for drug development.

Authors:  Subhajit Mukherjee; Sridhar Mani
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

Review 2.  Structural and functional insights into nuclear receptor signaling.

Authors:  Lihua Jin; Yong Li
Journal:  Adv Drug Deliv Rev       Date:  2010-08-17       Impact factor: 15.470

3.  Oligomerization behavior of the archaeal Sm2-type protein from Archaeoglobus fulgidus.

Authors:  Turgay Kilic; Sarah Sanglier; Alain Van Dorsselaer; Dietrich Suck
Journal:  Protein Sci       Date:  2006-09-08       Impact factor: 6.725

Review 4.  Orphan nuclear receptors in drug discovery.

Authors:  Yanhong Shi
Journal:  Drug Discov Today       Date:  2007-04-26       Impact factor: 7.851

Review 5.  The nuclear hormone receptor family round the clock.

Authors:  Michèle Teboul; Fabienne Guillaumond; Aline Gréchez-Cassiau; Franck Delaunay
Journal:  Mol Endocrinol       Date:  2008-07-24

Review 6.  Headway and hurdles in the clinical development of dietary phytochemicals for cancer therapy and prevention: lessons learned from vitamin A derivatives.

Authors:  Christina Y Yim; Pingping Mao; Michael J Spinella
Journal:  AAPS J       Date:  2014-01-16       Impact factor: 4.009

Review 7.  Vitamin A signaling and homeostasis in obesity, diabetes, and metabolic disorders.

Authors:  William S Blaner
Journal:  Pharmacol Ther       Date:  2019-01-29       Impact factor: 12.310

8.  Identification of potent RORβ modulators: Scaffold variation.

Authors:  Christelle Doebelin; Rémi Patouret; Ruben D Garcia-Ordonez; Mi Ra Chang; Venkatasubramanian Dharmarajan; Scott Novick; Anthony Ciesla; Sean Campbell; Laura A Solt; Patrick R Griffin; Theodore M Kamenecka
Journal:  Bioorg Med Chem Lett       Date:  2018-08-16       Impact factor: 2.823

9.  Modulation of retinoic acid receptor-related orphan receptor alpha and gamma activity by 7-oxygenated sterol ligands.

Authors:  Yongjun Wang; Naresh Kumar; Laura A Solt; Timothy I Richardson; Leah M Helvering; Christine Crumbley; Ruben D Garcia-Ordonez; Keith R Stayrook; Xi Zhang; Scott Novick; Michael J Chalmers; Patrick R Griffin; Thomas P Burris
Journal:  J Biol Chem       Date:  2009-12-04       Impact factor: 5.157

10.  Rorgamma (Rorc) is a common integration site in type B leukemogenic virus-induced T-cell lymphomas.

Authors:  Dana R Broussard; Mary M Lozano; Jaquelin P Dudley
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.